Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | EXEL | ARWR | ||
| Company | Biomarin Pharmaceuticals | Exelixis Inc | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 67.21 | 52.32 | 87.72 | ||
| High | 68.26 | 53.36 | 88.35 | ||
| Low | 66.84 | 52.11 | 85.98 | ||
| Last | 66.99 | 53.12 | 87.90 | ||
| Change | +0.35 | +0.80 | -0.80 | ||
| Percent Change | +0.53% | +1.53% | -0.90% | ||
| Volume | 1,942,400 | 1,290,500 | 974,900 | ||
| 20-Day Average Volume | 2,359,460 | 2,691,520 | 1,705,620 | ||
| Previous | 66.64 | 52.32 | 88.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 63.25 | 53.93 | 87.01 | ||
| 20-Day Raw Stochastic | 70.58% | 45.16% | 45.32% | ||
| 20-Day Relative Strength | 63.49 | 49.07 | 56.33 | ||
| Weighted Alpha | +22.83 | +37.88 | +198.57 | ||
| Today's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.68% since 08/11/26 | +3.49% since 08/11/26 | -1.50% since 08/11/26 | ||
| Low | 66.21 on 08/17/26 | 49.97 on 08/13/26 | 83.78 on 08/14/26 | ||
| High | 70.98 on 08/12/26 | 53.36 on 08/18/26 | 90.61 on 08/12/26 | ||
| 1-Month | |||||
| %Chg | +12.42% since 07/17/26 | -5.01% since 07/17/26 | +18.30% since 07/17/26 | ||
| Low | 57.42 on 07/23/26 | 49.97 on 08/13/26 | 71.00 on 07/20/26 | ||
| High | 70.98 on 08/12/26 | 56.95 on 08/05/26 | 95.49 on 07/22/26 | ||
| 3-Month | |||||
| %Chg | +34.87% since 05/18/26 | +6.58% since 05/18/26 | +18.86% since 05/18/26 | ||
| Low | 49.41 on 05/20/26 | 48.10 on 06/03/26 | 69.30 on 06/02/26 | ||
| High | 70.98 on 08/12/26 | 57.57 on 07/07/26 | 95.49 on 07/22/26 | ||
| 6-Month | |||||
| %Chg | +8.35% since 02/18/26 | +19.45% since 02/18/26 | +36.53% since 02/18/26 | ||
| Low | 49.26 on 05/18/26 | 39.71 on 03/02/26 | 54.02 on 03/13/26 | ||
| High | 70.98 on 08/12/26 | 57.57 on 07/07/26 | 95.49 on 07/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,899,771 | 12,963,954 | 12,494,015 | ||
| Shares Outstanding, K | 193,574 | 247,782 | 140,857 | ||
| Annual Sales, $M | 3,221,250,000 | 2,320,130,000 | 829,450,000 | ||
| Annual Net Income, $M | 348,900,000 | 782,570,000 | -1,630,000 | ||
| Last Qtr Sales, $M | 989,710,000 | 628,690,000 | 75,250,000 | ||
| Last Qtr Income, $M | 44,760,000 | 212,050,000 | -194,280,000 | ||
| 60-Month Beta | 0.24 | 0.44 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/06/26 | 0.91 on 08/05/26 | -1.36 on 08/04/26 | ||
| Latest Earnings Date | 10/26/26 | 11/03/26 | 11/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.10 | 16.22 | 0.00 | ||